Skip to main content
Wayne Marasco, MD, Allergy & Immunology, Boston, MA, Dana-Farber Cancer Institute

WayneAMarascoMD

Allergy & Immunology Boston, MA

Associate Professor of Medicine, Dana-Farber Cancer Institute

Are you Dr. Marasco?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 35 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Wayne Marasco, MD is an allergist/immunologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Michigan. He is affiliated with Dana-Farber Cancer Institute and is an Associate Professor of Medicine at Dana-Farber Cancer Institute.

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Infectious Disease, 1988 - 1990
  • University of Michigan Health System
    University of Michigan Health SystemResidency, Internal Medicine, 1986 - 1988
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1986

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1988 - 2023
  • MI State Medical License
    MI State Medical License 1987 - 1991
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Press Mentions

  • The Latest: Nobel Chemistry Findings "Used Today, Every Day"
    The Latest: Nobel Chemistry Findings "Used Today, Every Day"October 3rd, 2018
  • BioRestorative Therapies Announces the Creation of a Disc Advisory Committee
    BioRestorative Therapies Announces the Creation of a Disc Advisory CommitteeFebruary 27th, 2019
  • Immune Response to Flu Vaccine Linked to Recipients’ Ethnic Background
    Immune Response to Flu Vaccine Linked to Recipients’ Ethnic BackgroundFebruary 12th, 2016
  • Join now to see all

Grant Support

  • Study Of Broadly Neutralizing Antibody Generation To HIV Gp140 In Humanized MiceNational Institute Of Allergy And Infectious Diseases2010–2011
  • Broad Spectrum Neutralizing Human Abs To SARS And Related CoronavirusesNational Institute Of Allergy And Infectious Diseases2010–2011
  • Spore Core 1: Administrative, Evaluation And PlanningNational Cancer Institute2009–2011
  • Human MAB Cocktails To Prevent &Treat H5N1 Avian InfluenzaNational Institute Of Allergy And Infectious Diseases2007–2011
  • Anti-Hiv-1 TAT Human SFV Intrabody Gene Therapy Against SHIV In Rhesus MacaquesNational Center For Research Resources2003–2011
  • Novel Vaginal Microbicides Based On Stable Aav-Neutralizing Antibody Gene TransfeNational Institute Of Allergy And Infectious Diseases2010
  • Novel Vaginal Microbicides Based On Stable Aav-Neutralizing Antibody Gene TransfeNational Institute Of Allergy And Infectious Diseases2008–2009
  • Generation Of A Therapeutic Antibody Directed Against CCR4 For Patients WithNational Cancer Institute2008
  • Studies Of CCR5 Conformational Heterogeneity &Hiv EntryNational Institute Of Allergy And Infectious Diseases2004–2008
  • Human Antibodies And Targeted Vaccines Against SARS-COVNational Institute Of Allergy And Infectious Diseases2004–2008
  • Role Of SHP-1 Deregulation In HTLV-1 LeukemogenesisNational Cancer Institute2004–2008
  • Human Anti-Macaque CCR5 Mabs For Passive ImmunotherapyNational Institute Of Allergy And Infectious Diseases2003–2007
  • Genetic Retargeted Human T-Cells For RCC ImmunotherapyNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Anti-Hiv-1 TAT Human SFV Intrabody Gene TherapyNational Center For Research Resources2004
  • Targeting Human Cyclin T1 To Inhibit HIV-1 ReplicationNational Institute Of Allergy And Infectious Diseases2003–2004
  • Global Analysis Of Transcriptional Deregulation By HIV-1National Institute Of Allergy And Infectious Diseases2002–2003
  • Role Of Grb3-3 In T-Cell Activation &Hiv-1 ReplicationNational Institute Of Allergy And Infectious Diseases2001–2003
  • Intraceullular Anti-Tat Antibodies For AIDS Gene TherapyNational Institute Of Allergy And Infectious Diseases2000–2002
  • Gene Therapy By Phenotypic Knockout Of HIV CoreceptorsNational Institute Of Allergy And Infectious Diseases1998–2002
  • Human Antitat Intrabody Gene Therapy Against SHIVNational Center For Research Resources1999–2001
  • Intracellular Antitat Antibodies For AIDS Gene TherapyNational Institute Of Allergy And Infectious Diseases1995–1999
  • Gene Therapy Aids--A Recombinant Antibody-Based StrategyNational Institute Of Allergy And Infectious Diseases1994–1997
  • Repertoire Cloning Of Anti-Hiv-1 Gp120/Gp41 AntibodiesNational Institute Of Allergy And Infectious Diseases1993–1997
  • Mechanism Of Action Of The TAT Product Of HIV-1National Institute Of Allergy And Infectious Diseases1993
  • Cd23--Autocrine Growth Factor And ReceptorNational Cancer Institute1989–1991

Professional Memberships

Hospital Affiliations